 |
|
Tumors stopped from spreading to new sites
April 06, 2007For several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. Using a mouse model of breast cancer, researchers from Vanderbilt University have now generated evidence to suggest that treatment with TGF-beta inhibitors might help such patients.
In the study, which appears online on April 5 in advance of publication in the May print issue of the Journal of Clinical Investigation, Carlos Arteaga and colleagues show that treating mice with mammary tumors with either radiation or the chemotherapeutic drug doxorubicin increased the level of TGF-beta in their blood, the number of cancer cells in their blood, and the development of lung metastases. Treatment with an inhibitor of TGF-beta blocked the increased lung metastases. Furthermore, mice whose tumors did not express the receptor for TGF-beta did not develop increased incidence of lung metastases after treatment with radiation, indicating that TGF-beta affects the cancer cells directly, enhancing their metastatic function. This study has important clinical implications as it suggests that monitoring TGF-beta levels after primary therapy might indicate the patients most at risk of developing tumor metastases and that treatment with TGF-beta inhibitors might be of clinical benefit to these individuals.
Journal of Clinical Investigation
A genetic 'gang of 4' drives spread of breast cancer
Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs.
Curcumin halts spread of breast cancer in mice
Curcumin, the main ingredient of turmeric and the compound that gives curry its mustard-yellow color, inhibits metastasis to the lungs of mice with breast cancer.
Researchers identify gene set linked to breast cancer's spread to lungs
In a potential advance for the treatment of aggressive breast cancer, scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) have identified a set of genes in breast tumors that appear to predict if the disease will spread to the lungs and, once there, how virulent it will become.
More Lung Metastases Current Events and Lung Metastases News Articles
 | Lung Metastases And Isolated Lung Perfusion Surgical resection of lung metastases is a widely accepted procedure but long-term results are disappointing with a 5-year survival rate of approximately 40 per cent. The main prognostic factor is complete resection and a better survival is reported in patients with a single metastasis and a disease-free survival of more than 3 years. Re-operations are feasible but often patients become... |
| Therapy of Lung Metastases (Contributions to Oncology, Vol 30) by P. Drings | |
| Analysis of the clonal composition of individual lung metastases and the stability of the metastatic phenotype: A dissertation in anatomy by James S Tzeng | |
| Bone metastases in lung cancer: A clinical study in 200 consecutive patients with bronchogenic carcinoma and its therapeutic implications for small cell carcinoma by Heine Høi Hansen | |
 | Frozen Section Library: Lung (Frozen Section Library) by Timothy Craig Allen, Philip T. Cagle Frozen sections are performed for the purpose of rapid diagnosis while a patient is undergoing surgery, usually under general anesthesia, as a basis for making immediate treatment decisions. Therefore, frozen section diagnosis is often a highly demanding situation for the pathologist who must render a diagnosis quickly and a crucial determination for the patient and surgeon. In addition to the... |
 | Minimally Invasive Tumor Therapies (Recent Results in Cancer Research) In the age of the World Wide Web, informed patients continue to surprise oncologists with detailed questions about popular tumor therapies. Although minimally invasive tumor therapies (MITT) have become daily clinical practice for palliative treatment of liver tumors, the acceptance of these palliative modalities still varies enormously. In addition, promising results have been published for in... |
| Bronchogenic carcinoma;: A follow-up study of a surgically treated series with special reference to the prognostic significance of lymph node metastases, (Acta chirurgica Scandinavica) by Nils P Bergh |
| © 2008 BrightSurf.com |